Considering that TRIM21 functions as an E3 ligase, we analyzed the polyubiquitination of endogenous METTL3, which was further enhanced in pancreatic cancer cells treated with the proteasome inhibitor MG132 (Fig. 4A, B). The gene discussed is TRIM21; the disease is pancreatic neoplasm.